Evidence map›Paper›PMID 37860960›Full record

ArticleActa crystallographica. Section D, Structural biology2023

Crystal structures of the DExH-box RNA helicase DHX9.

Young Tae Lee, E Allen Sickmier, Simina Grigoriu, Jennifer Castro, P Ann Boriack-Sjodin

Open access · hybridAbstract read
In one paragraph

Article in Acta crystallographica. Section D, Structural biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Young Tae LeeAccent Therapeutics, 1050 Waltham Street, Lexington, MA 02421, USA.
E Allen SickmierAccent Therapeutics, 1050 Waltham Street, Lexington, MA 02421, USA.
Simina GrigoriuAccent Therapeutics, 1050 Waltham Street, Lexington, MA 02421, USA.
Jennifer CastroAccent Therapeutics, 1050 Waltham Street, Lexington, MA 02421, USA.
P Ann Boriack-SjodinAccent Therapeutics, 1050 Waltham Street, Lexington, MA 02421, USA.
Accent Therapeutics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DHX9 is a DExH-box RNA helicase with versatile functions in transcription, translation, RNA processing and regulation of DNA replication. DHX9 has recently emerged as a promising target for oncology, but to date no mammalian structures have been published. Here, crystal structures of human, dog and cat DHX9 bound to ADP are reported. The three mammalian DHX9 structures share identical structural folds. Additionally, the overall architecture and the individual domain structures of DHX9 are highly conserved with those of MLE, the Drosophila orthologue of DHX9 previously solved in complex with RNA and a transition-state analogue of ATP. Due to differences in the bound substrates and global domain orientations, the localized loop conformations and occupancy of dsRNA-binding domain 2 (dsRBD2) differ between the mammalian DHX9 and MLE structures. The combined effects of the structural changes considerably alter the RNA-binding channel, providing an opportunity to compare active and inactive states of the helicase. Finally, the mammalian DHX9 structures provide a potential tool for structure-based drug-design efforts.

Indexed as

Cat DiseasesDog DiseasesAnimalsCatsDEAD-box RNA HelicasesDNA ReplicationDogsHumansMammalsNeoplasm ProteinsRNARNA HelicasesDEAD-box RNA HelicasesDHX9 protein, humanNeoplasm ProteinsRNARNA HelicasesADPDExH boxDHX9RNA helicases

Identifiers

PMID37860960
PMCPMC10619421
OpenAlexW4387798930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.